Ubiquitination-mediated regulation of interferon responses

Growth Factors

Volumn 30, Issue 3, 2012, Pages 141-148

  Fuchs, Serge Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

E3 ligase; Interferon; Ubiquitin; Virus

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON; JANUS KINASE; JANUS KINASE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME; PROTEIN KINASE B; PROTEIN KINASE TYK2; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; VIRUS PROTEIN;

CARCINOGENESIS; CATALYSIS; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; DENGUE VIRUS; ENDOCYTOSIS; ENZYME MECHANISM; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HEPATITIS C; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MUMPS VIRUS; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SARS CORONAVIRUS; SIGNAL TRANSDUCTION; STOMATITIS; UBIQUITINATION; VIRUS CARCINOGENESIS; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; VIRUSES;

EID: 84861412643     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2012.669382     Document Type: Review

References (90)

1. Ali S, Nouhi Z, Chughtai N. 2003. SHP-2 regulates SOCS- 1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J Biol Chem 278:52021-52031.
2. Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A. 2009. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408-5418.
3. Bhattacharya S, HuangFu WC, Liu J, Veeranki S, Baker DP, Koumenis C, Diehl JA, Fuchs Y. 2010. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 285:2318-2325.
4. Bhattacharya S, Zheng H, Tzimas C, Carroll M, Baker DP, Fuchs Y. 2011. Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNalpha via accelerating the degradation of its receptor. Blood 118:4179-4187.
5. Bibeau-Poirier A, Servant J. 2008. Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling. Cytokine 43:359-367.
6. Boname JM, Lehner J. 2011. What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation? Viruses 3:118-131.
7. Boname JM, de Lima BD, Lehner PJ, Stevenson G. 2004. Viral degradation of the MHC class I peptide loading complex. Immunity 20:305-317.
8. Boname JM, Thomas M, Stagg HR, Xu P, Peng J, Lehner J. 2010. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 11: 210-220.
9. Bonnet MC, Weil R, Dam E, Hovanessian AG, Meurs F. 2000. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol 20: 4532-4542.
10. Burr ML, Cano F, Svobodova S, Boyle LH, Boname JM, Lehner J. 2011. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc Natl Acad Sci USA 108:2034-2039.
11. Chen ZJ. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7:758-765.
12. Cho IR, Oh M, Koh SS, Malilas W, Srisuttee R, Jhun BH, Pallegrini S, Fuchs SY, Chung YH. 2012. Hepatitis B virus X protein inhibits extracellular IFN-alpha-mediated signal transduction by downregulation of type I IFN receptor. Int J Mol Med 29:581-586.
13. Chu WM, Ostertag D, Li ZW, Chang L, Chen Y, Hu Y, Williams B, Perrault J, Karin M. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11: 721-731.
14. Crow MK, Kirou A. 2004. Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol 16:541-547.
15. Datta S, Hazari S, Chandra PK, Samara M, Poat B, Gunduz F, Wimley WC, Hauser H, Koster M, Lamaze C, Balart LA, Garry RF, Dash S. 2011. Mechanism of HCV's resistance to IFN-alpha in cell culture involves expression of functional IFN-alpha receptor 1. Virol J 8:351.
16. De Bie P, Ciechanover A. 2011. Ubiquitination of E3 ligases: Selfregulation of the ubiquitin system via proteolytic and nonproteolytic mechanisms. Cell Death Differ 18:1393-1402.
17. Donnelly RP, Kotenko V. 2010. Interferon-lambda: A new addition to an old family. J Interferon Cytokine Res 30:555-564.
18. Douglas JL, Gustin JK, Viswanathan K, Mansouri M, Moses AV, Fruh K. 2010. The great escape: Viral strategies to counter BST-2/tetherin. PLoS Pathog 6:e1000913.
19. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, Power UF, Johnston A. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 81:3428-3436.
20. Fuchs SY. 2002. The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biol Ther 1:337-341.
21. Fuchs SY, Spiegelman VS, Kumar G. 2004. The many faces of beta- TrCP E3 ubiquitin ligases: Reflections in the magic mirror of cancer. Oncogene 23:2028-2036.
22. Gao C, Guo H, Mi Z, Grusby MJ, Kuo C. 2007a. Osteopontin induces ubiquitin-dependent degradation of STAT1 in RAW264.7 murine macrophages. J Immunol 178:1870-1881.
23. Gao C, Mi Z, Guo H, Kuo C. 2007b. Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells. Neoplasia 9:699-706.
24. Garcin D, Marq JB, Strahle L, le Mercier P, KolakofskyD. 2002. All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295:256-265.
25. Gauzzi MC, Barbieri G, Richter MF, Uze G, Ling L, Fellous M, Pellegrini S. 1997. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc Natl Acad Sci USA 94: 11839-11844.
26. Goila-Gaur R, Strebel K. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5:51.
27. Guo H, Mi Z, Bowles DE, Bhattacharya SD, Kuo C. 2010. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages. J Biol Chem 285:37787-37796.
28. Hewitt EW, Duncan L, Mufti D, Baker J, Stevenson PG, Lehner J. 2002. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J 21:2418-2429.
29. Huangfu WC, Fuchs Y. 2010. Ubiquitination-dependent regulation of signaling receptors in cancer. Genes Cancer 1:725-734.
30. Huangfu WC, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY. 2012. Inflammatory signaling compromises cell responses to interferon alpha. Oncogene 31:161-172.
31. Ishii T, Kwon H, Hiscott J, Mosialos G, Koromilas E. 2001. Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 20:1900-1912.
32. Jackson PK. 2001. A new RING for SUMO: Wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev 15:3053-3058.
33. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Nakayama K, Yoshimura A. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 276:12530-12538.
34. Kamura T, Sato S, Haque D, Liu L, Kaelin WG, Jr, Conaway RC, Conaway W. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12: 3872-3881.
35. Kim TK, Maniatis T. 1996. Regulation of interferon-gammaactivated STAT1 by the ubiquitin-proteasome pathway. Science 273:1717-1719.
36. Kirkin V, Dikic I. 2011. Ubiquitin networks in cancer. Curr Opin Genet Dev 21:21-28.
37. Komuro A, Bamming D, Horvath M. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43: 350-358.
38. Kumar KG, TangW, Ravindranath AK, Clark WA, Croze E, Fuchs Y. 2003. SCF(HOS) ubiquitin ligase mediates the ligandinduced down-regulation of the interferon-alpha receptor. EMBO J 22:5480-5490.
39. Kumar KG, Krolewski JJ, Fuchs Y. 2004. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 279:46614-46620.
40. Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL, Fuchs Y. 2007. Site-specific ubiquitination exposes a linear motif to promote interferonalpha receptor endocytosis. J Cell Biol 179:935-950.
41. Kumar KG, Varghese B, Banerjee A, Baker DP, Constantinescu SN, Pellegrini S, Fuchs Y. 2008. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem 283:18566-18572.
42. Le VT, Trilling M, Wilborn M, Hengel H, Zimmermann A. 2008. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 89:2416-2426.
43. Lee Y, Hyung SW, Jung HJ, Kim HJ, Staerk J, Constantinescu SN, Chang EJ, Lee ZH, Lee SW, Kim H. 2008. The ubiquitinmediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. Blood 111: 885-893.
44. Lehner PJ, Hoer S, Dodd R, Duncan M. 2005. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207:112-125.
45. Liberatore RA, Bieniasz D. 2011. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc Natl Acad Sci USA 108:18097-18101.
46. Liu J, HuangFuWC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs Y. 2009. Virusinduced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 5:72-83.
47. Li Y, Gazdoiu S, Pan ZQ, Fuchs Y. 2004. Stability of homologue of Slimb F-box protein is regulated by availability of its substrate. J Biol Chem 279:11074-11080.
48. Li Q, Means R, Lang S, Jung U. 2007. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81:2117-2127.
49. Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V. 2009. HIV-1 Vpu neutralizes the antiviral factor tetherin/BST-2 by binding it and directing its beta-TrCP2- dependent degradation. PLoS Pathog 5:e1000574.
50. Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, Moses AV, Fruh K. 2009. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol 83:9672-9681.
51. Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S. 2006. TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J 397:31-38.
52. Minakshi R, Padhan K, Rani M, Khan N, Ahmad F, Jameel S. 2009. The SARS coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS One 4:e8342.
53. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli C. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 5:e1000450.
54. Nie L, Zhao Y, Wu W, Yang YZ, Wang HC, Sun H. 2011. Notchinduced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res 21: 754-769.
55. Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, Bieniasz P, Kellam P, Towers GJ, Neil J. 2010. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog 6:e1000843.
56. Payelle-Brogard B, Pellegrini S. 2010. Biochemical monitoring of the early endocytic traffic of the type I interferon receptor. J Interferon Cytokine Res 30:89-98.
57. Pfeffer LM. 2011. The role of nuclear factor kappaB in the interferon response. J Interferon Cytokine Res 31:553-559.
58. Piganis RA, De Weerd NA, Gould JA, Schindler CW, Mansell A, Nicholson SE, Hertzog J. 2011. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J Biol Chem 286:33811-33818.
59. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 5:375-386.
60. Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, Alvarez X, Dash S. 2010. SH2 modified STAT1 induces HLA-I expression and improves IFN-gamma signaling in IFN-alpha resistant HCV replicon cells. PLoS One 5:e13117.
61. Precious B, Childs K, Fitzpatrick-Swallow V, Goodbourn S, Randall E. 2005. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 79:13434-13441.
62. Puri M, Lemon K, Duprex WP, Rima BK, Horvath M. 2009. A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J Virol 83: 6347-6356.
63. Qian J, Zheng H, Huangfu WC, Liu J, Carbone CJ, Leu NA, Baker DP, Fuchs Y. 2011. Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1. PLoS Pathog 7:e1002065.
64. Ragimbeau J, Dondi E, Alcover A, Eid P, Uze G, Pellegrini S. 2003. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J 22:537-547.
65. Ramachandran A, Horvath M. 2009. Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res 29:531-537.
66. Ren J, Kolli D, Liu T, Xu R, Garofalo RP, Casola A, Bao X. 2011. Human metapneumovirus inhibits IFN-beta signaling by downregulating Jak1 and Tyk2 cellular levels. PLoS One 6: e24496.
67. Schmidt K, Wies E, Neipel F. 2011. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. J Virol 85:4530-4537.
68. Seth RB, Sun L, Chen J. 2006. Antiviral innate immunity pathways. Cell Res 16:141-147.
69. Shah KM, Stewart SE, Wei W, Woodman CB, O'Neil JD, Dawson CW, Young S. 2009. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene 28: 3903-3914.
70. Soond SM, Townsend PA, Barry SP, Knight RA, Latchman DS, Stephanou A. 2008. ERK and the F-box protein betaTRCP target STAT1 for degradation. J Biol Chem 283:16077-16083.
71. Straub CP, Lau WH, Preston FM, Headlam MJ, Gorman JJ, Collins PL, Spann M. 2011. Mutation of the elongin C binding domain of human respiratory syncytial virus non-structural protein 1 (NS1) results in degradation of NS1 and attenuation of the virus. Virol J 8:252.
72. Tanaka T, Soriano MA,Grusby J. 2005. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 22: 729-736.
73. Tanaka T, Yamamoto Y, Muromoto R, Ikeda O, Sekine Y, Grusby MJ, Kaisho T, Matsuda T. 2011. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3. Sci Signal 4:ra85.
74. Tenno T, Fujiwara K, Tochio H, Iwai K, Morita EH, Hayashi H, Murata S, Hiroaki H, Sato M, Tanaka K, Shirakawa M. 2004. Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells 9:865-875.
75. Trilling M, Le VT, Fiedler M, Zimmermann A, Bleifuss E, Hengel H. 2011. Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-gamma-stimulated cells. PLoS Pathog 7: e1002069.
76. Ulane CM, Horvath M. 2002. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160-166.
77. Ulane CM, Rodriguez JJ, Parisien JP, Horvath M. 2003. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 77:6385-6393.
78. Ulane CM, Kentsis A, Cruz CD, Parisien JP, Schneider KL, HorvathM. 2005. Composition and assembly of STAT-targeting ubiquitin ligase complexes: Paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol 79:10180-10189.
79. Ungureanu D, Silvennoinen O. 2005. SLIM trims STATs: Ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling. Sci STKE 2005:pe49.
80. Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol 22:3316-3326.
81. Uze G, Schreiber G, Piehler J, Pellegrini S. 2007. The receptor of the type I interferon family. Curr Top Microbiol Immunol 316: 71-95.
82. Viswanathan K, Fruh K, DeFilippis V. 2010. Viral hijacking of the host ubiquitin system to evade interferon responses. Curr Opin Microbiol 13:517-523.
83. Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Fruh K. 2011. BST2/tetherin enhances entry of human cytomegalovirus. PLoS Pathog 7:e1002332.
84. Yang CH, Murti A, Pfeffer SR, FanM, Du Z, Pfeffer M. 2008. The role of TRAF2 binding to the type I interferon receptor in alternative NF kappaB activation and antiviral response. J Biol Chem 283:14309-14316.
85. Yokosawa N, Yokota S, Kubota T, Fujii N. 2002. C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol 76: 12683-12690.
86. Yu J, Li X, Wang Y, Li B, Li H, Li Y, Zhou W, Zhang C, Rao Z, Bartlam M, Cao Y. 2011. PDlim2 selectively interacts with the PDZ binding motif of highly pathogenic avian H5N1 influenza A virus S1.NPLoS One 6:e19511.
87. Zhang D, Zhang E. 2011. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res 31: 119-130.
88. Zheng H, Qian J, Baker DP, Fuchs Y. 2011a. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J Biol Chem 286: 35733-35741.
89. Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs Y. 2011b. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood 118:4003-4006.
90. Zheng H, Qian J, Varghese B, Baker DP, Fuchs S. 2011c. Ligandstimulated downregulation of the alpha interferon receptor: Role of protein kinase D2. Mol Cell Biol 31:710-720.